Suppliers / PCAS

PCAS

France reconciled across 5 public records · 3 entities Updated 9 July 2026

PCAS is an API manufacturer based in France. It holds 31 active US drug master files. Its filings concentrate with MINSA (CR), INVIMA (CO) and ARCSA (EC). Its GMP standing is certified by ANSM (FR), US FDA and EMA. Its most recent recorded inspection, by US FDA, closed on 7 June 2024 as VAI.

31
active US DMFs
0
valid CEPs
10
registered plants 4 with an FDA FEI number
5
filings across 4 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
3 of 3 confirmed
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 7 June 2024 VAI US FDA
  • 10 January 2024 VAI US FDA
  • 31 March 2022 VAI US FDA
  • 19 March 2021 VAI US FDA
  • 13 September 2019 VAI US FDA
  • 7 March 2019 VAI US FDA
  • 14 September 2018 NAI US FDA
  • 7 September 2018 VAI US FDA
  • 15 September 2017 VAI US FDA
  • 23 September 2016 NAI US FDA
  • 29 April 2016 VAI US FDA
  • 15 May 2015 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Finland, Finland 3003469991
France, France 3002808156
France, France 3014417426
Aramon, France Not on file
Porcheville, France Not on file
France, France 3003623331

4 further sites are on record.

What they file, and where

Molecule Regulators Docs
Oxybutynin SFDA (Saudi Arabia), US FDA 3
Timolol US FDA 3
Baclofen SFDA (Saudi Arabia), US FDA 2
Clonidine US FDA 2
Esomeprazole US FDA 2
Alimemazine US FDA 1
Apraclonidine US FDA 1
Articaine US FDA 1
Ciclopirox US FDA 1
Ciclopirox Olamine SFDA (Saudi Arabia) 1
Show all 31 molecules on file
Cinacalcet US FDA 1
Clomifene US FDA 1
Desipramine US FDA 1
Disopyramide US FDA 1
Enclomiphene US FDA 1
Estetrol US FDA 1
Glycopyrronium US FDA 1
Mepivacaine US FDA 1
Mequitazine PMDA (Japan) 1
Olopatadine US FDA 1
Pindolol US FDA 1
Praziquantel US FDA 1
Roluperidone US FDA 1
Sodium Divalproate SFDA (Saudi Arabia) 1
Tazarotene US FDA 1
Valproic Acid US FDA 1
オキシブチニン塩酸塩 PMDA (Japan) 1
ピペリドレート塩酸塩 PMDA (Japan) 1
塩酸オキシブチニン PMDA (Japan) 1
臭化メペンゾラート PMDA (Japan) 1
酒石酸アリメマジン PMDA (Japan) 1

Also appears on these molecule pages

Show 6 more molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 2 None
INVIMA (CO) 1 None
ARCSA (EC) 1 None
Health Canada 1 None
ANSM (FR) None 52
US FDA None 1
EMA None 1

Questions about PCAS

Does PCAS hold a US DMF or a CEP?
PCAS holds 31 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is PCAS FDA-registered?
4 sites operated by PCAS carry an FDA establishment identifier (FEI), which means they are registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did PCAS's last inspection go?
The most recent inspection on record closed on 7 June 2024 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 19 inspections are on file.
Where does PCAS manufacture?
10 registered sites are on record, in Finland and France (Finland, France and Aramon among others). Every site is listed on this page with the register it came from.
What does PCAS make?
31 molecules are on record against PCAS, including Oxybutynin, Timolol, Baclofen and Clonidine. Each links through to that molecule's full manufacturer list.
Which regulators recognise PCAS's GMP?
Current GMP certificates are on record from ANSM (FR), US FDA and EMA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. PCAS comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 7 June 2024.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates